Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Noom offers cut-price compounded GLP-1 drug for obesity Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US
After several studies showed it to have a significant impact on weight loss as well, the FDA-approved semaglutide for use for patients with obesity
Even better, semaglutide also slows the rate at which food passes through the digestive system
Some need surgery
doi: 10.1016/j.molp.2015.08.010 71 SinghY
These medications work with the bodys natural hormone systems to help regulate appetite, blood sugar, and metabolism
US$ 21.68
US$ 21.19
US$ 22.27
US$ 29.32
US$ 22.17
US$ 27.13
US$ 26.09
